Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HTRF analysis of soluble huntingtin in PHAROS PBMCs.

Neurology - 24 Sept 2013

Moscovitch-Lopatin Miriam, Goodman Rachel E, Eberly Shirley, Ritch James J, Rosas H Diana, Matson Samantha, Matson Wayne, Oakes David, Young Anne B, Shoulson Ira, Hersch Steven M

Abstract excerpt

OBJECTIVE: We measured the levels of mutant huntingtin (mtHtt) and total huntingtin (tHtt) in blood leukocytes from Prospective Huntington At-Risk Observational Study (PHAROS) subjects at 50% risk of carrying the Huntington disease mutation using a homogeneous time-resolved fluorescence (HTRF) as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Trials as Topic
Share to Double-Blind Method
Share to Fluorescence Resonance Energy Transfer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Frontal Lobe

Share to Huntingtin Protein

Share to Huntington Disease

Share to Postmortem Changes

Share to Trinucleotide Repeat Expansion

Source

Open in PubMed Open full text

Identifiers

PMID: 23966247
DOI: 10.1212/WNL.0b013e3182a55ede
PMCID: PMC3795598

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23966247-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HTRF analysis of soluble huntingtin in PHAROS PBMCs.PMID 23966247Read ↗

Mutant huntingtin fragmentation in immune cells tracks Huntington's disease progression.Semantic proximity Read ↗

Analysis of mutant and total huntingtin expression in Huntington's disease murine models.Semantic proximity Read ↗

Quantification of huntingtin protein species in Huntington's disease patient leukocytes using optimised electrochemiluminescence immunoassays.Semantic proximity Read ↗

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities.Semantic proximity Read ↗

Quantifying mutant huntingtin protein in human cerebrospinal fluid to support the development of huntingtin-lowering therapiesSemantic proximity Read ↗

Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cellsSemantic proximity Read ↗

Development of an ELISA assay for the quantification of soluble huntingtin in human blood cells.Semantic proximity Read ↗

Time-resolved FRET screening identifies small molecular modifiers of mutant Huntingtin conformational inflexibility in patient-derived cells.Semantic proximity Read ↗

Polyglutamine- and temperature-dependent conformational rigidity in mutant huntingtin revealed by immunoassays and circular dichroism spectroscopy.Semantic proximity Read ↗

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.Semantic proximity Read ↗

High Levels of Mutant Huntingtin Protein in Tear Fluid From Huntington’s Disease Gene Expansion CarriersSemantic proximity Read ↗

Development of novel bioassays to detect soluble and aggregated Huntingtin proteins on three technology platformsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.